Anna Martling

Prof. Dr. Anna Martling

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2012 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
JSJ Segelman
J Segelman
FGF Granath
F Granath
THT Holm
T Holm
MMM Machado
M Machado
HMH Mahteme
H Mahteme
AMAnna Martling
Anna Martling
Background: This was a population-based cohort study to determine the incidence, prevalence and risk factors for peritoneal carcinomatosis (PC) from colorectal cancer. Methods: Prospectively collected data were obtained from the Regional Quality Registry. The Cox proportional hazards regression model was used for multivariable analysis of clinicopathological factors to determine independent predictors of PC. Results: All 11 124 patients with colorectal cancer in Stockholm County during 1995–2007 were included and followed until 2010. In total, 924 patients (8·3 per cent) had synchronous or metachronous PC. PC was the first and only localization of metastases in 535 patients (4·8 per cent). The prevalence of synchronous PC was 4·3 per cent (477 of 11 124). The cumulative incidence of metachronous PC was 4·2 per cent (447 of 10 646). Independent predictors for metachronous PC were colonic cancer (hazard ratio (HR) 1·77, 95 per cent confidence interval 1·31 to 2·39; P = 0·002 for right-sided colonic cancer), advanced tumour (T) status (HR 9·98, 3·10 to 32·11; P < 0·001 for T4), advanced node (N) status (HR 7·41, 4·78 to 11·51; P < 0·001 for N2 with fewer than 12 lymph nodes examined), emergency surgery (HR 2·11, 1·66 to 2·69; P < 0·001) and non-radical resection of the primary tumour (HR 2·75, 2·10 to 3·61; P < 0·001 for R2 resection). Patients aged > 70 years had a decreased risk of metachronous PC (HR 0·69, 0·55 to 0·87; P = 0·003). Conclusion: PC is common in patients with colorectal cancer and is associated with identifiable risk factors.

15 August 2001 in Cancer
Verified
Journal Article
Open access
PDF file
AMAnna Martling
Anna Martling
HJHemming Johansson
Hemming Johansson
LRLars Erik Rutqvist
Lars Erik Rutqvist
SGStockholm Colorectal Cancer Study Group
Stockholm Colorectal Cancer Study Group
THTorbjörn Holm
Torbjörn Holm
BCBjörn Cedermark
Björn Cedermark
BACKGROUND The Stockholm II trial is a population‐based prospective randomized trial on preoperative radiotherapy in rectal carcinoma. METHODS Eligibility criteria were age younger than 80 years and biopsy‐proven adenocarcinoma of the rectum judged resectable for cure with an abdominal procedure. Between 1987 and 1993, 557 patients were included. Patients were randomized to preoperative radiotherapy (RT+) followed by surgery within a week (n = 272) or surgery alone (RT−; n = 285). Radiotherapy was given with 25 grays in 1 week to the rectum and pararectal tissues. Curative resection was performed in 481 patients (86%). Median follow‐up was 8.8 years. RESULTS Among patients who underwent curative surgery, the incidence of pelvic recurrence was 12% (RT+) and 25% (RT−), respectively (P < 0.001). The overall survival rate in irradiated patients who underwent curative surgery was improved (46%) versus (39%; P < 0.03). For all included patients, the difference was 39% (RT+) compared with 36% (RT−; P = 0.2). Within 6 months of surgery, 13 of 272 (5%) of the irradiated patients died of intercurrent disease versus 4 of 285 (1%) of the nonirradiated (P = 0.02). Cardiovascular death was the main cause of intercurrent death and occurred in 35 of 272 (13%) of the irradiated patients compared with 20 of 285 (7%) among the nonirradiated (P = 0.07). CONCLUSIONS Preoperative short‐term radiotherapy reduces the risk of pelvic recurrence and can improve survival after curative surgery for rectal carcinoma. An increased risk of intercurrent death may reduce the benefit especially in elderly patients. Cancer 2001;92:896–902. © 2001 American Cancer Society.

12 February 2010 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
DPD Pettersson
D Pettersson
BCB Cedermark
B Cedermark
THT Holm
T Holm
CRC Radu
C Radu
LPL Påhlman
L Påhlman
AMAnna Martling
Anna Martling
To address issues regarding the fractionation of radiotherapy (RT) and timing of surgery for rectal cancer, a multicentre trial has randomized patients to preoperative short-course RT with two different intervals to surgery, or long-course RT with delayed surgery. The present interim analysis assessed feasibility, compliance and complications after RT and surgery. Some 303 patients were randomized to either short-course RT (5 × 5 Gy) and surgery within 1 week (group 1), short-course RT and surgery after 4–8 weeks (group 2) or long-course RT (25 × 2 Gy) and surgery after 4–8 weeks (group 3). Demographic data were similar between groups and there were few protocol violations (5·0–6 per cent). Eight patients (2·6 per cent) developed radiation-induced acute toxicity. There were no significant differences in postoperative complications between groups (46·6, 40·0 and 32 per cent in groups 1, 2 and 3 respectively; P = 0·164). Patients receiving short-course RT with surgery 11–17 days after the start of RT had the highest complication rate (24 of 37). Compliance was acceptable and severe acute toxicity was low, irrespective of fractionation. Short-course RT with immediate surgery had a tendency towards more postoperative complications, but only if surgery was delayed beyond 10 days after the start of RT. Registration number: NCT00904813 (http://www.clinicaltrials.gov).

1 August 2002 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
AMAnna Martling
Anna Martling
BCB Cedermark
B Cedermark
HJH Johansson
H Johansson
LRL E Rutqvist
L E Rutqvist
THT Holm
T Holm
Background: With conventional blunt surgical resection of rectal cancer, local recurrence rates are high and the individual surgeon putatively influences patient outcome. With total mesorectal excision (TME) local recurrence rates have been reduced and intersurgeon variability may be less important. The ‘TME project’ was a collaborative project that included surgical workshops in Stockholm between 1994 and 1997. The aim of this study was to assess the impact of the project on the practice of rectal cancer surgery in Stockholm and to analyse whether surgeon case volume and participation in the workshops influenced patient outcome. Methods: All 652 patients who had an abdominal resection for rectal cancer in Stockholm between 1995 and 1997 were included. Outcome was compared in patients operated on by teams that included high-volume surgeons (more than 12 operations per year) with teams that included low-volume surgeons (12 operations or fewer per year), as well as between teams that including workshop participants and non-participants. Results: Forty-six surgeons operated on the 652 patients. Five high-volume surgeons operated on 48 per cent of the patients. In these, outcome was significantly better than in patients treated by low-volume surgeons (local recurrence rate 4 versus 10 per cent (P = 0·02); rate of rectal cancer death 11 versus 18 per cent (P = 0·007)). Twenty-six surgeons were workshop participants and performed 93 per cent of the operations. Radiotherapy, TME and sphincter-preserving surgery were more common among patients treated by workshop participants. Conclusion: The TME project has had an impact on rectal cancer surgical practice in Stockholm. Variability in patient outcome was mainly related to case volume, with better results obtained in patients treated by high-volume surgeons.

2 December 2006 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
GPG. Palmer
G. Palmer
AMAnna Martling
Anna Martling
BCB. Cedermark
B. Cedermark
THT. Holm
T. Holm

31 January 2005 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
AMAnna Martling
Anna Martling
THT Holm
T Holm
LRL E Rutqvist
L E Rutqvist
HJH Johansson
H Johansson
BMB J Moran
B J Moran
BCB Cedermark
B Cedermark
Background: Total mesorectal excision (TME) and use of adjuvant radiotherapy are major advances in the treatment of rectal cancer that have emerged in the past 20 years. The aim of this study was to evaluate the effects of an initiative to teach the TME technique on outcomes at 5 years after surgery. Methods: TME-based surgery was introduced in Stockholm in 1994. The study population comprised all 447 patients who underwent abdominal operations for rectal cancer in Stockholm County during 1995 and 1996. Outcomes were compared with those in the Stockholm I (790 patients) and Stockholm II (542 patients) radiotherapy trials. Results: The permanent stoma rate was reduced from 60·3 and 55·3 per cent in the Stockholm I and II trials respectively to 26·5 per cent in the TME project (P < 0·001). Five-year local recurrence rates decreased from 21·9 and 19·1 per cent to 8·2 per cent respectively (P < 0·001). Five-year cancer-specific survival rates increased from 66·0 and 65·7 per cent in the Stockholm trials to 77·3 per cent in the TME project (hazard ratio 0·62 (95 per cent confidence interval 0·49 to 0·80); P < 0·001). Conclusion: A surgical teaching programme had a major impact on rectal cancer outcome.